A detailed history of Park Avenue Securities LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Park Avenue Securities LLC holds 95,554 shares of NVO stock, worth $11.3 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
95,554
Previous 110,771 13.74%
Holding current value
$11.3 Million
Previous $15.8 Million 28.04%
% of portfolio
0.13%
Previous 0.19%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$119.07 - $145.42 $1.81 Million - $2.21 Million
-15,217 Reduced 13.74%
95,554 $11.4 Million
Q2 2024

Jul 09, 2024

BUY
$122.71 - $146.91 $961,064 - $1.15 Million
7,832 Added 7.61%
110,771 $15.8 Million
Q1 2024

Apr 10, 2024

BUY
$102.11 - $135.92 $1.51 Million - $2.01 Million
14,775 Added 16.76%
102,939 $13.2 Million
Q4 2023

Jan 10, 2024

BUY
$87.78 - $105.45 $294,853 - $354,206
3,359 Added 3.96%
88,164 $9.12 Million
Q3 2023

Oct 26, 2023

BUY
$90.94 - $199.54 $4.07 Million - $8.94 Million
44,787 Added 111.92%
84,805 $7.71 Million
Q2 2023

Jul 14, 2023

BUY
$155.98 - $172.65 $309,308 - $342,364
1,983 Added 5.21%
40,018 $6.48 Million
Q1 2023

Apr 18, 2023

SELL
$132.34 - $159.14 $3,176 - $3,819
-24 Reduced 0.06%
38,035 $6.05 Million
Q4 2022

Jan 24, 2023

BUY
$102.55 - $135.33 $41,225 - $54,402
402 Added 1.07%
38,059 $0
Q3 2022

Nov 01, 2022

BUY
$95.28 - $116.93 $197,324 - $242,162
2,071 Added 5.82%
37,657 $3.75 Million
Q2 2022

Jul 27, 2022

BUY
$103.24 - $121.81 $1.07 Million - $1.27 Million
10,412 Added 41.36%
35,586 $3.97 Million
Q1 2022

Apr 29, 2022

BUY
$93.1 - $112.54 $893,201 - $1.08 Million
9,594 Added 61.58%
25,174 $2.8 Million
Q4 2021

Apr 08, 2022

BUY
$95.88 - $117.08 $26,654 - $32,548
278 Added 1.82%
15,580 $1.74 Million
Q3 2021

Oct 21, 2021

BUY
$84.42 - $106.62 $152,462 - $192,555
1,806 Added 13.38%
15,302 $1.47 Million
Q2 2021

Aug 05, 2021

BUY
$67.66 - $84.76 $164,210 - $205,712
2,427 Added 21.93%
13,496 $1.13 Million
Q1 2021

Apr 28, 2021

BUY
$67.06 - $75.82 $133,315 - $150,730
1,988 Added 21.89%
11,069 $746,000
Q4 2020

Jan 20, 2021

BUY
$63.89 - $73.8 $76,348 - $88,191
1,195 Added 15.15%
9,081 $634,000
Q3 2020

Nov 03, 2020

BUY
$63.69 - $70.22 $67,957 - $74,924
1,067 Added 15.65%
7,886 $548,000
Q2 2020

Jul 30, 2020

BUY
$58.54 - $67.94 $399,184 - $463,282
6,819 New
6,819 $447,000
Q1 2020

Apr 28, 2020

SELL
$49.46 - $64.78 $222,372 - $291,250
-4,496 Closed
0 $0
Q4 2019

Feb 04, 2020

SELL
$49.86 - $58.26 $73,393 - $85,758
-1,472 Reduced 24.66%
4,496 $260,000
Q3 2019

Oct 18, 2019

BUY
$47.54 - $53.43 $283,718 - $318,870
5,968 New
5,968 $309,000
Q2 2019

Jul 26, 2019

SELL
$46.79 - $52.47 $240,173 - $269,328
-5,133 Closed
0 $0
Q1 2019

May 02, 2019

BUY
$46.36 - $52.63 $237,965 - $270,149
5,133 New
5,133 $268,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $266B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Park Avenue Securities LLC Portfolio

Follow Park Avenue Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.